Yoshinori Ino Selected Research

Lectins

1/2020

Clinicopathological significance of core 3 O-glycan synthetic enzyme, β1,3-N-acetylglucosaminyltransferase 6 in pancreatic ductal adenocarcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yoshinori Ino Research Topics

Disease

29	Neoplasms (Cancer) 01/2021 - 01/2002
11	Adenocarcinoma 01/2021 - 08/2002
11	Neoplasm Metastasis (Metastasis) 12/2016 - 01/2002
6	Colorectal Neoplasms (Colorectal Cancer) 11/2021 - 01/2005
4	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022 - 01/2013
4	Carcinoma (Carcinomatosis) 01/2021 - 05/2003
2	Ovarian Neoplasms (Ovarian Cancer) 08/2021 - 01/2021
2	Chronic Pancreatitis 10/2020 - 04/2019
2	Carcinogenesis 01/2019 - 03/2003
2	Stomach Neoplasms (Stomach Cancer) 06/2005 - 04/2004
2	Breast Neoplasms (Breast Cancer) 01/2005 - 09/2002
1	Cholangiocarcinoma 11/2021
1	Neoplasms, Cystic, Mucinous, and Serous 11/2021
1	Bullous Pemphigoid (Pemphigoid) 02/2021
1	Squamous Cell Carcinoma of Head and Neck 02/2021
1	Pharyngeal Neoplasms 02/2021
1	Thymus Neoplasms (Thymus Neoplasm) 06/2020
1	Thymoma (Thymic Carcinoma) 06/2020
1	Primitive Neuroectodermal Tumors (PNET) 10/2017
1	Necrosis 12/2016
1	Gallbladder Neoplasms (Gallbladder Cancer) 12/2015
1	Prostatic Neoplasms (Prostate Cancer) 01/2013
1	Hypoxia (Hypoxemia) 01/2013
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 07/2004
1	Focal Segmental Glomerulosclerosis (Glomerulosclerosis, Focal) 07/2004
1	Esophageal Squamous Cell Carcinoma 01/2004
1	Thyroid Neoplasms (Thyroid Cancer) 09/2003
1	Papillary Carcinoma 09/2003
1	Adenoma (Adenomas) 03/2003
1	Intestinal Polyps 03/2003

Drug/Important Bio-Agent (IBA)

11	Cadherins (E-Cadherin)IBA 09/2009 - 01/2002
7	Proteins (Proteins, Gene)FDA Link 11/2021 - 03/2003
6	Biological ProductsIBA 01/2020 - 03/2003
5	Glycoproteins (Glycoprotein)IBA 04/2005 - 01/2002
3	LigandsIBA 06/2020 - 01/2011
3	Peptides (Polypeptides)IBA 10/2017 - 07/2004
3	beta CateninIBA 09/2009 - 03/2003
3	CateninsIBA 10/2005 - 07/2002
2	EnzymesIBA 11/2021 - 01/2020
2	polysulfideIBA 08/2021 - 01/2021
2	AntigensIBA 02/2021 - 08/2020
2	Amino Acids FDA Link 01/2019 - 07/2004
2	Indicators and Reagents (Reagents)IBA 01/2013 - 01/2005
2	Biomarkers (Surrogate Marker)IBA 03/2011 - 01/2005
2	Monoclonal AntibodiesIBA 04/2005 - 05/2003
2	Galectin 3 (LGALS3)IBA 05/2003 - 08/2002
1	Ephrin-A5 (AL-1)IBA 01/2022
1	CollagenIBA 01/2022
1	N-acetyltalosaminuronic acid (NAT)IBA 01/2022
1	Aquaporin 1IBA 11/2021
1	UDP-GlcNAc GalNAc-peptide beta1,3-N-acetylglucosaminyltransferaseIBA 11/2021
1	sulfur-32IBA 01/2021
1	monobromobimaneIBA 01/2021
1	Ambroxol (Mucosolvan)IBA 01/2021
1	Cisplatin (Platino)FDA LinkGeneric 01/2021
1	CystathionineIBA 01/2021
1	Expectorants (Mucolytics)IBA 01/2021
1	LyasesIBA 01/2021
1	PlatinumIBA 01/2021
1	SulfurIBA 01/2021
1	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 10/2020
1	embelinIBA 10/2020
1	E-SelectinIBA 10/2020
1	HLA-G Antigens (HLA G)IBA 08/2020
1	Histocompatibility Antigens Class IIBA 08/2020
1	HLA Antigens (Human Leukocyte Antigens)IBA 08/2020
1	Interleukin-13 Receptor alpha2 SubunitIBA 05/2020
1	Polysaccharides (Glycans)IBA 01/2020
1	MucinsIBA 01/2020
1	LectinsIBA 01/2020
1	GAP-43 Protein (GAP 43 Protein)IBA 04/2019
1	SurvivinIBA 10/2017
1	Oncogene Protein v-cblIBA 12/2015
1	Carbonic Anhydrase IXIBA 01/2013
1	OrnithineIBA 01/2013
1	Arginine (L-Arginine)FDA Link 01/2013
1	ArginaseIBA 01/2013
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 01/2012
1	Small Interfering RNA (siRNA)IBA 01/2012
1	Complement C9 (Complement Component 9)IBA 03/2011
1	Blood Proteins (Serum Proteins)IBA 03/2011
1	Apolipoprotein A-I (Apolipoprotein A1)IBA 03/2011
1	CXC ChemokinesIBA 01/2011
1	Cell Adhesion MoleculesIBA 01/2011
1	Tyrosine (L-Tyrosine)FDA Link 09/2009
1	Transforming Growth Factor alpha (TGF-alpha)IBA 09/2009
1	Carrier Proteins (Binding Protein)IBA 09/2009
1	Irinotecan (Camptosar)FDA LinkGeneric 06/2005
1	Thromboplastin (Tissue Factor)IBA 04/2005
1	Tetracycline (Achromycin)FDA LinkGeneric 01/2005
1	Microfilament Proteins (Actin Binding Proteins)IBA 01/2005
1	Membrane Glycoproteins (Membrane Glycoprotein)IBA 10/2004
1	RNA (Ribonucleic Acid)IBA 07/2004
1	Decitabine FDA Link 01/2004
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 03/2003

Therapy/Procedure

2	Drug Therapy (Chemotherapy) 01/2021 - 06/2020
2	Immunotherapy 06/2020 - 03/2018
1	Neoadjuvant Therapy 01/2022
1	Therapeutics 10/2017
1	Adjuvant Chemotherapy 12/2016